Evidence map›Paper›PMID 33532535›Full record

ArticleGynecologic oncology reports2021

Factors associated with delays in time to treatment initiation in Colombian women with cervical cancer: A cross-sectional analysis.

Juliana Alexandra Hernández Vargas, Paula Ximena Ramírez Barbosa, Ana María Valbuena-Garcia, Lizbeth Acuña, Jaime A González-Diaz

Abstract read
In one paragraph

Article in Gynecologic oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juliana Alexandra Hernández VargasEpidemiologist at Cuenta de Alto Costo, Fondo Colombiano de Enfermedades de Alto Costo, Bogotá, Colombia.
Paula Ximena Ramírez BarbosaAnalytics specialist at Cuenta de Alto Costo, Fondo Colombiano de Enfermedades de Alto Costo, Bogotá, Colombia.
Ana María Valbuena-GarciaEpidemiologist, Knowledge Management Coordinator at Cuenta de Alto Costo, Fondo Colombiano de Enfermedades de Alto Costo, Bogotá, Colombia.
Lizbeth AcuñaEpidemiologist, Executive Director at Cuenta de Alto Costo, Fondo Colombiano de Enfermedades de Alto Costo, Bogotá, Colombia.
Jaime A González-DiazInternist, Hematologist-Oncologist at Asociación Colombiana de Hematología y Oncología, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer (CC) is one of the leading causes of morbidity in upper-middle income countries such as Colombia. Several studies have reported poor prognosis when treatment is delayed. We aimed to describe the factors associated with delays in time to treatment initiation (TTI) in Colombian women with CC. Cross-sectional analysis including newly diagnosed cases of CC during 2018 and reported to the National Administrative Cancer Registry. TTI was defined as days from diagnosis to the first treatment (chemotherapy, radiation, or surgery). Linear and multinomial logistic regression models were estimated to analyze the association of interest. 1,249 new cases of CC were analyzed (26.98%

Indexed as

CAC, Cuenta de Alto Costo (High Cost Diseases Fund)Cervical cancerDANE, Departamento Administrativo Nacional de Estadística (Department for National Statistics)Delayed treatmentGLOBOCAN, The Global Cancer ObservatoryHDI, Human Development IndexHealth insuranceIQR, Interquartile rangeNACR, National Administrative Cancer RegistryTime-to-treatment

Identifiers

PMID33532535
PMCPMC7822946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.